IL21R and breast benign neoplasm: In our study, the AUC results showed that the IL21R hypomethylation based on FFPE tissue samples has high reliability and accuracy in distinguishing BC patients from subjects with benign breast tumours, especially for BC cases at Stage 0 & I, and BC cases with ER-negative, PR-negative, or triple-negative tumours.